Cargando…
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y(12) inhibitors in opiate-treated ST-elevation myocardial infarction (STEMI) patients underg...
Autores principales: | Sumaya, Wael, Parker, William A.E., Judge, Heather M., Hall, Ian R., Orme, Rachel C., Adam, Zulfiquar, Richardson, James D., Rothman, Alexander M.K., Morgan, Kenneth P., Gunn, Julian P., Storey, Robert F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352377/ https://www.ncbi.nlm.nih.gov/pubmed/32543247 http://dx.doi.org/10.1080/09537104.2020.1779925 |
Ejemplares similares
-
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)
por: Sumaya, Wael, et al.
Publicado: (2018) -
The Perioperative Management of Antithrombotic Therapies Using Enoxaparin
por: Hwang, Hun-Gyu, et al.
Publicado: (2017) -
Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
por: Orme, Rachel C., et al.
Publicado: (2018) -
Patient-tailored antithrombotic therapy following percutaneous coronary intervention
por: van der Sangen, Niels M R, et al.
Publicado: (2021) -
Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)